ReitsWhat went wrong for Life Science ReitIts IPO was oversubscribed, but it now trades at a discount. Is there any way back for loyal investors?1 April 2025Save
Ideas of the WeekRetail is having a renaissance – and this Reit is taking advantageRetail used to be a dirty word in property but if you pick the right brands in the right location, your strategy can be on point27 March 2025Save
PropertyActivism in the property sector – who will be next?Activists and private equity are circling the listed property sector21 March 2025Save
NewsLand Securities’ transformation hit by lacklustre office marketA lack of deals in London’s office market means the welcomed change in portfolio mix is taking time19 March 2025Save
ReitsPHP enters the Assura buyout sagaHarry Hyman tells the Investors’ Chronicle why PHP’s offer allows Assura shareholders to ‘preserve some upside’12 March 2025Save
ReitsWhat investors should make of the bid for AssuraPrivate equity has the £3.1bn healthcare portfolio in its sights6 March 2025Save
ReitsReits taking advantage of rising care home demandAgeing populations and low supply – the fundamentals are stacked in care home investors' favour4 March 2025Save
ReitsWhy the office property market is brightening upHigh quality offices in prime central London are back to having very low vacancy rates19 February 2025Save
FTSE 350 Special ReportThe worst is over for Reits – but it still pays to pick wiselyFTSE 350 Review: Another year of consolidation awaits investors, and scale will become even more important6 February 2025Save
ReitsWhy it's time to rethink retail propertyThere are more ways to invest than shopping centres – we pick out the best ways to buy back into this bargain space21 January 2025Save
.jpg?source=specialist-components&quality=low)
